AI & Healthcare News ・ 💚 Chronic disease self-management

Can AI redesign mRNA to last weeks, not days?

Drug Discovery News · 10/20 15:51 UTC

ScionxBio licenses its xRNA TERA platform to Sanofi. The platform targets chronic protein-deficiency diseases with AI-engineered mRNA that lasts weeks, not days.

Read the original (Drug Discovery News)

See it in the digest → ・ See this issue →